Skip to main content

Table 2 Changes in the peripheral blood cell proportion before and after insulin and AHSCT treatments

From: Immune response after autologous hematopoietic stem cell transplantation in type 1 diabetes mellitus

  Insulin-only group AHSCT group
Insulin-0M Insulin-12M AHSCT-0M AHSCT-12M
WBC (×109/L) 6.01 ± 1.00 5.96 ± 1.38 5.74 ± 1.78 4.16 ± 1.17*
Monocyte (%) 6.37 ± 2.13 7.12 ± 1.49 6.91 ± 1.39 7.40 ± 0.32
Lymphocyte (%) 37.80 ± 8.46 42.39 ± 5.90 42.94 ± 5.55 33.64 ± 7.01*
CD3+CD4+ T cell (%) 41.96 ± 6.44 43.57 ± 8.70 39.89 ± 8.25 30.59 ± 5.30**
CD3+CD8+ T cell (%) 31.73 ± 7.99 27.65 ± 7.93 31.49 ± 5.72 30.83 ± 11.34
TCR(α/β) (%) 69.94 ± 6.43 71.95 ± 4.72 72.56 ± 6.46 57.90 ± 10.49*
  1. Data presented as mean ± SD
  2. AHSCT autologous hematopoietic stem cell transplantation, 0 M at baseline, 12 M at 12 months
  3. *P < 0.05, **P < 0.01, compared with the Insulin-12 M group